我勒个去 : It has been falling for 4 consecutive days, sigh.

TheRealWendy : HOLD. It’s going to 90 by December if not earlier. Launched their new OTC product today

TheRealWendy : Don’t believe the hype. Dexcom took a hit because it missed earnings and it’s competitor capitalized by chumming the press with nonsense. Dexcom is held by Vanguard, BlackRock hedge funds and they have INCREASED positions. Get in now while it’s on fire sale.  Also, DXCM is releasing a new OTC product this months and they are already the preferred brand for hospitals across the US.

Umami66 : take profits now while you still can

Kevin Travers : I am looking for the same thing, no idea why it is falling like this

Kevin Travers : as far as I can tell, because Eli lilly posted that diabetese study news with monjaro, and Dexcom is developing a competitor type of drug

TheRealWendy : Don’t believe the hype. Dexcom took a hit because it missed earnings and it’s competitor capitalized by chumming the press with nonsense. Dexcom is held by Vanguard, BlackRock hedge funds and they have INCREASED positions. Get in now while it’s on fire sale.  Also, DXCM is releasing a new OTC product this months and they are already the preferred brand for hospitals across the US.